Surgery Partners, Inc.
SGRY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $4 | $3 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $4 | $3 | $3 | $3 |
| Enterprise Value | $6 | $7 | $5 | $7 |
| Revenue | $3 | $3 | $3 | $2 |
| % Growth | 13.5% | 8% | 14.1% | – |
| Gross Profit | $1 | $1 | $1 | $0 |
| % Margin | 23.9% | 23.6% | 22.6% | 22.1% |
| EBITDA | $1 | $0 | $0 | $0 |
| % Margin | 16.1% | 16.3% | 18.1% | 18% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5.4% | -0.4% | -2.2% | -3.2% |
| EPS Diluted | -1.33 | -0.095 | -0.59 | -1.12 |
| % Growth | -1,304.4% | 83.9% | 47.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |